Skip to content

Characteristics and Prognosis of Moderate or Severe Tricuspid Regurgitation

Clinical and Echocardiographic Characteristics and Prognosis of trIcuspid regurgiTation (EPIT): Prospective and Retrospective Follow-up of a Cohort of Patients With Moderate or Severe Tricuspid Regurgitation

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03546231
Acronym
EPIT
Enrollment
400
Registered
2018-06-06
Start date
2018-03-15
Completion date
2026-06-01
Last updated
2026-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tricuspid Valve Disease

Keywords

Tricuspid regurgitation, tricuspid valve, surgery, outcome, prognosis, mortality, right ventricle, asymptomatic

Brief summary

The tricuspid valve : its evaluation is relatively difficult in echocardiography and the management of tricuspid valve diseases remains poorly codified.

Detailed description

The tricuspid valve is often called the "forgotten valve" because its evaluation is relatively difficult in echocardiography and the management of tricuspid valve diseases remains poorly codified. In developed countries, TR is mainly functional, related to a remodeling of the right cavities in response to an increase in the load conditions. This remodeling induces a dilation of the tricuspid ring and / or a "tenting" of the tricuspid leaflets. Once TR is present, a vicious circle settles because TR increases right ventricle dilation. Transthoracic echocardiography is the key examination allowing noninvasive, quantification and assessment of hemodynamic repercussions of TR. TR remains asymptomatic for a long time, often diagnosed with a significant delay at the stage of advanced right heart failure. At this stage, the surgical risk is important, at least more important than for left heart valve diseases and it is therefore essential to define the right time for proposing valvular surgery to patients. Indeed, TR is an independent factor of mortality and only surgical treatment improves the prognosis. Current guidelines remain vague given the low number of prognostic studies and of their contradictory results often influenced by the significant comorbidities of patients, the presence of pulmonary hypertension or left heart valve disease. Only a minority of patients (\<1%) is referred to surgery because operative mortality is often judged unacceptable in elderly patients or in cases of advanced right ventricular dysfunction. The constitution of a prospective and retrospective cohort will improve the state of knowledge on etiologies, natural history, prognosis and management of patients with moderate or severe TR.

Interventions

None listed

Sponsors

Centre Hospitalier Universitaire, Amiens
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Months to No maximum

Inclusion criteria

* Age \>18 ans * inclusion criteria: moderate or severe tricuspid regurgitation *

Exclusion criteria

Refusal to participate/ prior surgery of the tricuspid valve

Design outcomes

Primary

MeasureTime frameDescription
Overall survival5 YearsIt corresponds to the delay between the diagnostic and the date of death.

Countries

France

Contacts

CONTACTChristophe TRIBOUILLOY, Pr
Tribouilloy.Christophe@chu-amiens.fr03 22 45 58 85
PRINCIPAL_INVESTIGATORChristophe TRIBOUILLOY, Pr

CHU AMIENS-PICARDIE

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 16, 2026